Clinical Trials on Alzheimer's Disease (AD)

Total 378307 results

Hoffmann-La Roche

Completed

A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants

Alzheimers Disease

United States
Avid Radiopharmaceuticals

Completed

The Feasibility of Florbetapir Quantitation

Alzheimers Disease

United States
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)

Alzheimers Disease

United States
University of Aarhus

Completed

Identifying Potential Effects of Liraglutide on Degenerative Changes

Alzheimers Disease

Denmark
Baycrest

Completed

Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia: A Pilot Study (LDIR-CT-AD)

Dementia Alzheimers

Canada
Elizabeth K Rhodus
National Institute on Aging (NIA)

Recruiting

Person-Environment Fit for Persons With Dementia

Alzheimer Disease | Dementia Alzheimers

United States
Bijan Najafi, PhD
BioSensics

Recruiting

Care Coordination System for People With Dementia

Dementia | Alzheimer Disease | Dementia Alzheimers

United States
Alzinova AB
CRST Oy

Recruiting

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Alzheimer Disease | Dementia Alzheimers | Dementia, Mild

Finland
University of California, Los Angeles

Withdrawn

FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD (FDDNP)

Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES) | Suspected Alzheimer's Disease (AD)
Molecular NeuroImaging
Institute for Neurodegenerative Disorders

Completed

Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls

Alzheimers Disease

United States
Novartis Pharmaceuticals
Amgen; Banner Alzheimer's Institute

Terminated

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS2)

Alzheimers Disease

Spain, United States, Belgium, Italy, Germany, Australia, Israel, Taiwan, Japan, Canada, Korea, Republic of, United Kingdom, France, China, Argentina, Finland, Singapore, Portugal, Chile, Mexico, Switzerland, Netherlands, Iceland, Puerto... and more
Novartis Pharmaceuticals
National Institute on Aging (NIA); Amgen; Banner Alzheimer's Institute

Terminated

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS1)

Alzheimers Disease

United States, Belgium, United Kingdom, Germany, Australia, Canada, Spain, Finland, Switzerland, Netherlands
Molecular NeuroImaging
Institute for Neurodegenerative Disorders

Completed

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

Alzheimers Disease

United States
Novo Nordisk A/S

Active, not recruiting

A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

Alzheimers Disease

United States, Canada, Italy, Sweden, Denmark, Switzerland
Cognito Therapeutics, Inc.

Recruiting

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) (Hope)

Cognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditions

United States
Institute for Neurodegenerative Disorders
Molecular NeuroImaging

Completed

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

Alzheimers Disease

United States
University Hospital, Clermont-Ferrand

Not yet recruiting

Interest of the Reborn® Doll as a TO in the Care of Residents With Alzheimer's Disease or a Related Disorder (PROTMA)

Dementia Alzheimers

France
Barcelonabeta Brain Research Center, Pasqual Maragall...

Completed

Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients (EMOCUIDA)

Psychological Support to Caregivers of Azlheimer's Patients

Spain
Molecular NeuroImaging
Life Molecular Imaging SA

Completed

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Alzheimer's Disease (AD) | Progressive Supranuclear Palsy (PSP) | Frontal Temporal Dementia (FTD) | Cortical Basal Syndrome (CBS)

United States
Cognito Therapeutics, Inc.

Active, not recruiting

Multi-Center Study of Sensory Stimulation to Improve Brain Function (Overture)

Cognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Dementia, Alzheimer Type | Dementia Alzheimers | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, Mild

United States
Oslo University Hospital
South Eastern Area Health Service

Unknown

Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type (ALZ-vit)

Mild Cognitive Impairment | Alzheimers Disease

Norway
UCB Biopharma SRL

Recruiting

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) (cosMOG)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

United States, Australia, Belgium, Czechia, France, Germany, Italy, Japan, Korea, Republic of, Mexico, Spain, Sweden, Switzerland, Turkey, Portugal, United Kingdom, Brazil, Ukraine, Taiwan
Ascentys Ltd

Not yet recruiting

Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease (G:DATA)

Dementia Alzheimers

United Kingdom
University Hospital, Basel, Switzerland

Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease (CogCheck-MC)

Neurocognitive Disorders | Cognition Disorders | Mild Cognitive Impairment | Dementia Alzheimers

Switzerland
Stemedica Cell Technologies, Inc.
Stemedica International SA

Recruiting

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Alzheimer Dementia

United States
Assiut University

Not yet recruiting

Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes

Alzheimer Dementia
William Beaumont Hospitals

Completed

Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders

Dementia | Alzheimers Disease

United States
Massachusetts Institute of Technology

Recruiting

Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy

Alzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Alzheimer's

United States
Alnylam Pharmaceuticals

Recruiting

A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

Early-Onset Alzheimer Disease

United Kingdom, United States, Netherlands, Canada
Mayo Clinic

Recruiting

48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease

Early Onset Alzheimer Disease

United States
University of Southern California
Alzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...

Recruiting

Financial Incentives and Recruitment to the APT Webstudy (FIND-AD)

Dementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's Disease

United States
University of Southern California
National Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaborators

Active, not recruiting

TRC-PAD Program: In-Clinic Trial-Ready Cohort (TRC-PAD)

Dementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's Disease

United States
University of Rostock
DZNE, German Center for Neurodegenerative Disorders, Germany

Unknown

Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI (ECIF)

Dementia of the Alzheimer Type

Germany
Rambam Health Care Campus

Unknown

Pain Perception in Alzheimer's Disease

Dementia Alzheimer Type

Israel
Aphios

Not yet recruiting

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Dementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
Mclean Hospital
National Institute on Aging (NIA)

Not yet recruiting

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside (Emerald-NRAD)

Neurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Cognitive Dysfunction | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Mental Disorder | Neurocognitive Dysfunction | Dementia Alzheimers
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Alzheimer's Desease

Japan
University of Wisconsin, Madison
National Institute on Aging (NIA); Arizona State University

Not yet recruiting

Speech Pattern Evaluation and Analysis for Knowledge of AD (SPEAK-AD)

Wisconsin Alzheimer's Disease Research Center | Wisconsin Registry for Alzheimer's Prevention

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Alzheimer's Disease

Alzheimer's

China
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension (FUTURE-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United States
Novoic Limited

Recruiting

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST Extension (AMYPRED-PAST)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Novoic Limited

Completed

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping (AMYPRED-US)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United States
Novoic Limited

Completed

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech (AMYPRED)

Alzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's Disease

United Kingdom
Istanbul University - Cerrahpasa (IUC)

Not yet recruiting

Association of Cognition With Functional Mobility in People With Alzheimer's Disease

Dementia, Alzheimer Type | Alzheimer's Disease | Alzheimer Dementia

Turkey
Cognition Therapeutics
National Institute on Aging (NIA); Alzheimer's Clinical Trials Consortium

Recruiting

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

Early Alzheimer's Disease

United States
Emory University
National Institute on Aging (NIA)

Recruiting

Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease

Prodromal Alzheimer's Disease

United States
Alzheon Inc.

Active, not recruiting

Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease

Early Alzheimer's Disease

Netherlands, Czechia
University of Minnesota

Completed

Concurrent Aerobic Exercise and Virtual Reality Cognitive Training (VRCT)

Preclinical Alzheimer's Disease

United States
GemVax & Kael

Withdrawn

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

Moderate Alzheimer's Disease
Zealand University Hospital
Rigshospitalet, Denmark

Unknown

Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression (DEMPROG)

Mild Cognitive Impairment | Alzheimers Disease

Denmark

Clinical Trials on Alzheimer's Disease (AD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations